Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Fortress Biotech files $125M mixed securities shelf  17:06
07/23/21
07/23
17:06
07/23/21
17:06
FBIO

Fortress Biotech

$3.07 /

-0.07 (-2.23%)

 
ShowHide Related Items >><<
FBIO Fortress Biotech
$3.07 /

-0.07 (-2.23%)

FBIO Fortress Biotech
$3.07 /

-0.07 (-2.23%)

06/17/21 B. Riley
Fortress Biotech price target lowered to $8 from $9 at B. Riley
04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
04/05/21 B. Riley
Fortress Biotech price target raised to $9 from $8 at B. Riley
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
FBIO Fortress Biotech
$3.07 /

-0.07 (-2.23%)

FBIO Fortress Biotech
$3.07 /

-0.07 (-2.23%)

FBIO Fortress Biotech
$3.07 /

-0.07 (-2.23%)

Initiation
Fly Intel: Top five analyst initiations » 10:00
07/23/21
07/23
10:00
07/23/21
10:00
THC

Tenet Healthcare

$70.71 /

+0.73 (+1.04%)

, PLUG

Plug Power

$27.44 /

+0.12 (+0.44%)

, OGN

Organon

$30.42 /

-0.5 (-1.62%)

, MP

MP Materials

$34.74 /

+0.42 (+1.22%)

, PLL

Piedmont Lithium

$55.65 /

-0.03 (-0.05%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tenet Healthcare (THC) reinstated with a Buy at Citi. 2. Plug Power (PLUG) initiated with a Buy at Citi. 3. Organon (OGN) initiated with a Buy, $35 target at Citi. 4. MP Materials (MP) initiated with a Buy at DA Davidson. 5. Piedmont Lithium (PLL) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
THC Tenet Healthcare
$70.71 /

+0.73 (+1.04%)

PLUG Plug Power
$27.44 /

+0.12 (+0.44%)

PLL Piedmont Lithium
$55.65 /

-0.03 (-0.05%)

OGN Organon
$30.42 /

-0.5 (-1.62%)

MP MP Materials
$34.74 /

+0.42 (+1.22%)

THC Tenet Healthcare
$70.71 /

+0.73 (+1.04%)

07/23/21 RBC Capital
Tenet Healthcare price target raised to $83 from $78 at RBC Capital
07/23/21 Citi
Tenet Healthcare reinstated with a Buy at Citi
07/23/21 Deutsche Bank
Tenet Healthcare price target raised to $80 from $69 at Deutsche Bank
07/09/21 Seaport Global
Seaport initiates five in Healthcare Facilities and Services with three Buys
PLUG Plug Power
$27.44 /

+0.12 (+0.44%)

07/23/21 Citi
Plug Power initiated with a Buy at Citi
07/15/21
Fly Intel: Top five analyst initiations
07/15/21 Seaport Global
Plug Power initiated with a Buy at Seaport Global
06/30/21
Fly Intel: Top five analyst initiations
OGN Organon
$30.42 /

-0.5 (-1.62%)

07/23/21 Citi
Organon initiated with a Buy, $35 target at Citi
07/22/21 Citi
Organon initiated with a Buy at Citi
06/25/21 Evercore ISI
Evercore ISI finds positive news on legal front for Organon's 'biggest drug'
06/15/21 JPMorgan
Organon initiated with a Neutral at JPMorgan
MP MP Materials
$34.74 /

+0.42 (+1.22%)

07/23/21 DA Davidson
MP Materials initiated with a Buy at DA Davidson
06/29/21 Baird
Baird starts MP Materials at Outperform, sees 'superior multiple' warranted
06/29/21 Baird
MP Materials initiated with an Outperform at Baird
06/16/21 JPMorgan
MP Materials initiated with an Overweight at JPMorgan
PLL Piedmont Lithium
$55.65 /

-0.03 (-0.05%)

07/23/21 DA Davidson
Piedmont Lithium initiated with a Buy at DA Davidson
07/21/21 B. Riley
Piedmont selloff on mine project concerns an opportunity, says B. Riley
06/11/21 JPMorgan
Piedmont Lithium price target lowered to $84 from $86 at JPMorgan
06/10/21 Evercore ISI
Piedmont Lithium price target raised to $95 from $75 at Evercore ISI
THC Tenet Healthcare
$70.71 /

+0.73 (+1.04%)

PLUG Plug Power
$27.44 /

+0.12 (+0.44%)

MP MP Materials
$34.74 /

+0.42 (+1.22%)

  • 24
    Mar
  • 24
    Mar
  • 27
    Jan
  • 17
    Nov
  • 22
    Oct
  • 12
    Aug
PLUG Plug Power
$27.44 /

+0.12 (+0.44%)

PLL Piedmont Lithium
$55.65 /

-0.03 (-0.05%)

MP MP Materials
$34.74 /

+0.42 (+1.22%)

THC Tenet Healthcare
$70.71 /

+0.73 (+1.04%)

PLUG Plug Power
$27.44 /

+0.12 (+0.44%)

PLL Piedmont Lithium
$55.65 /

-0.03 (-0.05%)

OGN Organon
$30.42 /

-0.5 (-1.62%)

MP MP Materials
$34.74 /

+0.42 (+1.22%)

PLUG Plug Power
$27.44 /

+0.12 (+0.44%)

PLL Piedmont Lithium
$55.65 /

-0.03 (-0.05%)

OGN Organon
$30.42 /

-0.5 (-1.62%)

MP MP Materials
$34.74 /

+0.42 (+1.22%)

Initiation
Plug Power initiated with a Buy at Citi » 08:18
07/23/21
07/23
08:18
07/23/21
08:18
PLUG

Plug Power

$27.32 /

-0.73 (-2.60%)

Citi analyst P.J. Juvekar…

Citi analyst P.J. Juvekar initiated coverage of Plug Power with a Buy rating and $35 price target. Plug Power is "leading the way" in the nascent hydrogen economy, which is "at the cusp of a breakout," Juvekar tells investors. Plug has "positioned itself at the center of the hydrogen economy" with its unique vertical integration from making electrolyzers to hydrogen production, delivery and building fuel cell modules, Juvekar said.

ShowHide Related Items >><<
PLUG Plug Power
$27.32 /

-0.73 (-2.60%)

PLUG Plug Power
$27.32 /

-0.73 (-2.60%)

07/15/21
Fly Intel: Top five analyst initiations
07/15/21 Seaport Global
Plug Power initiated with a Buy at Seaport Global
06/30/21
Fly Intel: Top five analyst initiations
06/30/21 RBC Capital
Plug Power initiated with an Outperform at RBC Capital
PLUG Plug Power
$27.32 /

-0.73 (-2.60%)

  • 27
    Jan
  • 17
    Nov
  • 12
    Aug
PLUG Plug Power
$27.32 /

-0.73 (-2.60%)

PLUG Plug Power
$27.32 /

-0.73 (-2.60%)

PLUG Plug Power
$27.32 /

-0.73 (-2.60%)

Initiation
Argenx initiated with a Hold at Deutsche Bank » 06:54
07/23/21
07/23
06:54
07/23/21
06:54
ARGX

Argenx

$316.37 /

-2.7 (-0.85%)

Deutsche Bank analyst…

Deutsche Bank analyst Emmanuel Papadakis initiated coverage of Argenx with a Hold rating and EUR 250 price target. The analyst sees a full valuation at current share levels and believes the "likely cadence of near-term events looks finely balanced from a risk-reward perspective."

ShowHide Related Items >><<
ARGX Argenx
$316.37 /

-2.7 (-0.85%)

ARGX Argenx
$316.37 /

-2.7 (-0.85%)

07/22/21 Wedbush
Argenx price target raised to $362 from $344 at Wedbush
07/19/21 Wolfe Research
Argenx assumed with an Outperform at Wolfe Research
06/18/21 UBS
Argenx initiated with a Buy at UBS
06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
ARGX Argenx
$316.37 /

-2.7 (-0.85%)

  • 03
    Feb
ARGX Argenx
$316.37 /

-2.7 (-0.85%)

Thursday
Syndicate
Clene files to sell 2.1M shares of common stock for holders  17:04
07/22/21
07/22
17:04
07/22/21
17:04
CLNN

Clene

$9.21 /

+0.27 (+3.02%)

 
ShowHide Related Items >><<
CLNN Clene
$9.21 /

+0.27 (+3.02%)

CLNN Clene
$9.21 /

+0.27 (+3.02%)

05/20/21 Maxim
Clene initiated with a Buy at Maxim
05/20/21 Maxim
Clene initiated with a Buy at Maxim
05/03/21 Cantor Fitzgerald
Clene initiated with an Overweight at Cantor Fitzgerald
03/29/21 Roth Capital
Clene to release results from four Phase 2 trials in 2H, says Roth Capital
CLNN Clene
$9.21 /

+0.27 (+3.02%)

Recommendations
Seres trial news 'disappointing,' but an isolated story, says JMP » 15:23
07/22/21
07/22
15:23
07/22/21
15:23
MCRB

Seres Therapeutics

$8.72 /

-12.075 (-58.07%)

, EVLO

Evelo Biosciences

$10.10 /

-2.77 (-21.52%)

, KLDO

Kaleido Biosciences

$6.09 /

-1.15 (-15.88%)

JMP Securities analyst…

JMP Securities analyst Gobind Singh reiterated a Market Perform rating on Seres Therapeutics (MCRB) after the company reported that the Phase 2 ECO-RESET trial did not meet its primary endpoint of clinical remission at week 10. Singh said that while the news is "disappointing" and "an obvious setback" for SER-287, he views the result as an isolated story with a specific microbiome-based therapeutic that does not have any read-through to other MBT companies, including Evelo Biosciences (EVLO) and Kaleido Biosciences (KLDO). In addition, Singh noted he would be a buyer on both Evelo and Kaleido, both Outperform-rated, as the recent selloff is unwarranted, making the risk/reward even more attractive.

ShowHide Related Items >><<
MCRB Seres Therapeutics
$8.72 /

-12.075 (-58.07%)

KLDO Kaleido Biosciences
$6.09 /

-1.15 (-15.88%)

EVLO Evelo Biosciences
$10.10 /

-2.77 (-21.52%)

MCRB Seres Therapeutics
$8.72 /

-12.075 (-58.07%)

07/22/21 Piper Sandler
Piper trims Seres Therapeutics price target to $32, would buy on weakness
07/22/21 Cowen
Seres Therapeutics' Phase IIb study fails to demonstrate efficacy, says Cowen
07/09/21 Chardan
Seres Therapeutics assumed with a Buy at Chardan
07/02/21 Canaccord
Seres Therapeutics deal with Nestle validates high interest, says Canaccord
EVLO Evelo Biosciences
$10.10 /

-2.77 (-21.52%)

07/09/21 Chardan
Evelo Biosciences assumed with a Neutral at Chardan
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 Cantor Fitzgerald
Evelo Biosciences initiated with an Overweight at Cantor Fitzgerald
06/23/21 Cantor Fitzgerald
Evelo Biosciences initiated with an Overweight at Cantor Fitzgerald
KLDO Kaleido Biosciences
$6.09 /

-1.15 (-15.88%)

07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
12/23/20 JMP Securities
Kaleido Biosciences initiated with an Outperform at JMP Securities
MCRB Seres Therapeutics
$8.72 /

-12.075 (-58.07%)

KLDO Kaleido Biosciences
$6.09 /

-1.15 (-15.88%)

EVLO Evelo Biosciences
$10.10 /

-2.77 (-21.52%)

  • 04
    Feb
  • 29
    Jan
  • 13
    Aug
MCRB Seres Therapeutics
$8.72 /

-12.075 (-58.07%)

KLDO Kaleido Biosciences
$6.09 /

-1.15 (-15.88%)

EVLO Evelo Biosciences
$10.10 /

-2.77 (-21.52%)

Conference/Events
Roth Capital sustainability analyst holds an analyst/industry conference call » 10:25
07/22/21
07/22
10:25
07/22/21
10:25
ENPH

Enphase Energy

$180.13 /

+0.57 (+0.32%)

, GNRC

Generac

$447.40 /

+0.26 (+0.06%)

, SEDG

SolarEdge

$260.76 /

+1.91 (+0.74%)

, NOVA

Sunnova Energy

$36.17 /

-0.16 (-0.44%)

, RUN

Sunrun

$52.89 /

-0.06 (-0.11%)

, SPWR

SunPower

$24.75 /

-0.665 (-2.62%)

, SUNW

Sunworks

$8.89 /

-0.25 (-2.74%)

Managing Director &…

Managing Director & Sustainability Analyst Shen, along with the Founder of Ohm Analytics, Chris Collins, discuss the forecasts for 2Q and 3Q U.S. residential solar installations, including a preview of forecasts by inverter type on an Analyst/Industry conference call to be held on July 22 at 11 am. Webcast Link

ShowHide Related Items >><<
SUNW Sunworks
$8.89 /

-0.25 (-2.74%)

SPWR SunPower
$24.75 /

-0.665 (-2.62%)

SEDG SolarEdge
$260.76 /

+1.91 (+0.74%)

RUN Sunrun
$52.89 /

-0.06 (-0.11%)

NOVA Sunnova Energy
$36.17 /

-0.16 (-0.44%)

GNRC Generac
$447.40 /

+0.26 (+0.06%)

ENPH Enphase Energy
$180.13 /

+0.57 (+0.32%)

ENPH Enphase Energy
$180.13 /

+0.57 (+0.32%)

07/21/21 JPMorgan
Enphase Energy price target raised to $238 from $210 at JPMorgan
07/19/21 BofA
SolarEdge price target raised to $279 from $276 at BofA
07/15/21 Seaport Global
Enphase Energy initiated with a Neutral at Seaport Global
07/15/21 Piper Sandler
Enphase Energy price target raised to $202 from $195 at Piper Sandler
GNRC Generac
$447.40 /

+0.26 (+0.06%)

07/07/21 Piper Sandler
Generac price target raised to $480 from $410 at Piper Sandler
06/25/21
Fly Intel: Top five analyst initiations
06/25/21 Citi
Generac initiated with a Buy at Citi
SEDG SolarEdge
$260.76 /

+1.91 (+0.74%)

07/21/21 JPMorgan
SolarEdge price target raised to $373 from $337 at JPMorgan
07/15/21 Piper Sandler
SolarEdge price target raised to $342 from $340 at Piper Sandler
07/02/21 Goldman Sachs
SolarEdge price target raised to $322 from $290 at Goldman Sachs
NOVA Sunnova Energy
$36.17 /

-0.16 (-0.44%)

07/21/21 JPMorgan
Sunnova Energy price target raised to $56 from $51 at JPMorgan
07/20/21
Fly Intel: Top five analyst initiations
07/20/21 RBC Capital
Sunnova Energy initiated with an Outperform at RBC Capital
07/15/21 Piper Sandler
Sunnova Energy price target lowered to $52 from $55 at Piper Sandler
RUN Sunrun
$52.89 /

-0.06 (-0.11%)

07/21/21 JPMorgan
Sunrun price target raised to $86 from $81 at JPMorgan
07/13/21 Credit Suisse
Sunrun assumed with an Outperform at Credit Suisse
06/24/21 Stephens
Sunrun initiated with an Overweight at Stephens
06/16/21 Morgan Stanley
Sunrun price target raised to $91 from $86 at Morgan Stanley
SPWR SunPower
$24.75 /

-0.665 (-2.62%)

07/15/21 Piper Sandler
SunPower price target lowered to $26 from $28 at Piper Sandler
07/13/21 Credit Suisse
SunPower assumed with an Underperform at Credit Suisse
07/02/21 Goldman Sachs
SunPower price target raised to $25 from $22 at Goldman Sachs
06/01/21 Roth Capital
Watering down of AB1139 positive for residential solar, says Roth Capital
SUNW Sunworks
$8.89 /

-0.25 (-2.74%)

04/26/21 Roth Capital
Sunworks resumed with a Neutral at Roth Capital
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
SPWR SunPower
$24.75 /

-0.665 (-2.62%)

SEDG SolarEdge
$260.76 /

+1.91 (+0.74%)

RUN Sunrun
$52.89 /

-0.06 (-0.11%)

NOVA Sunnova Energy
$36.17 /

-0.16 (-0.44%)

GNRC Generac
$447.40 /

+0.26 (+0.06%)

ENPH Enphase Energy
$180.13 /

+0.57 (+0.32%)

  • 16
    Dec
  • 01
    Dec
  • 12
    Nov
  • 21
    Oct
  • 13
    Oct
  • 14
    Aug
SUNW Sunworks
$8.89 /

-0.25 (-2.74%)

SPWR SunPower
$24.75 /

-0.665 (-2.62%)

SEDG SolarEdge
$260.76 /

+1.91 (+0.74%)

RUN Sunrun
$52.89 /

-0.06 (-0.11%)

NOVA Sunnova Energy
$36.17 /

-0.16 (-0.44%)

GNRC Generac
$447.40 /

+0.26 (+0.06%)

ENPH Enphase Energy
$180.13 /

+0.57 (+0.32%)

SUNW Sunworks
$8.89 /

-0.25 (-2.74%)

SPWR SunPower
$24.75 /

-0.665 (-2.62%)

SEDG SolarEdge
$260.76 /

+1.91 (+0.74%)

RUN Sunrun
$52.89 /

-0.06 (-0.11%)

GNRC Generac
$447.40 /

+0.26 (+0.06%)

ENPH Enphase Energy
$180.13 /

+0.57 (+0.32%)

Options
Largest borrow rate increases among liquid names » 08:45
07/22/21
07/22
08:45
07/22/21
08:45
GOEV

Canoo

$8.76 /

+0.21 (+2.46%)

, LIT

Litton Ind

$81.61 /

+3.6 (+4.61%)

, LABD

Daily S&P Biotech Bear 3x Shares

$21.23 /

-0.71 (-3.24%)

, SOLO

ElectraMeccanica

$3.73 /

+0.09 (+2.47%)

, OWL

Blue Owl Capital

$13.63 /

+0.36 (+2.71%)

, GT

Goodyear Tire

$15.88 /

+0.23 (+1.47%)

, XELA

Exela Technologies

$2.92 /

+0.17 (+6.18%)

, CL

Colgate-Palmolive

$82.19 /

-0.49 (-0.59%)

, VLDR

Velodyne Lidar

$8.55 /

+0.12 (+1.42%)

, FTCV

FinTech Acquisition Corp. V

$10.66 /

+0.15 (+1.43%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Canoo (GOEV) 22.79% +3.48, Global X Lithium (LIT) 1.21% +0.46, Direxion S&P Biotech Bear 3X (LABD) 12.08% +0.42, Electrameccanica Vehicles Corp (SOLO) 5.36% +0.35, Blue Owl Capital (OWL) 89.24% +0.34, Goodyear Tire (GT) 0.59% +0.34, (XELA) 19.74% +0.29, Colgate Palmolive (CL) 0.67% +0.28, Velodyne Lidar (VLDR) 8.25% +0.16, and FinTech Acquisition Corp V (FTCV) 20.91% +0.14.

ShowHide Related Items >><<
XELA Exela Technologies
$2.92 /

+0.17 (+6.18%)

VLDR Velodyne Lidar
$8.55 /

+0.12 (+1.42%)

SOLO ElectraMeccanica
$3.73 /

+0.09 (+2.47%)

OWL Blue Owl Capital
$13.63 /

+0.36 (+2.71%)

LABD Daily S&P Biotech Bear 3x Shares
$21.23 /

-0.71 (-3.24%)

GT Goodyear Tire
$15.88 /

+0.23 (+1.47%)

GOEV Canoo
$8.76 /

+0.21 (+2.46%)

FTCV FinTech Acquisition Corp. V
$10.66 /

+0.15 (+1.43%)

CL Colgate-Palmolive
$82.19 /

-0.49 (-0.59%)

GOEV Canoo
$8.76 /

+0.21 (+2.46%)

06/21/21 R.F. Lafferty
Canoo 'well ahead' of other EV startups, says R.F. Lafferty
05/18/21 Roth Capital
Canoo price target lowered to $7 from $12 at Roth Capital
04/20/21 BofA
Canoo initiated with an Underperform at BofA
04/20/21 BofA
Canoo initiated with an Underperform at BofA
LIT Litton Ind
$81.61 /

+3.6 (+4.61%)

LABD Daily S&P Biotech Bear 3x Shares
$21.23 /

-0.71 (-3.24%)

SOLO ElectraMeccanica
$3.73 /

+0.09 (+2.47%)

12/16/20 Stifel
ElectraMeccanica initiated with a Buy at Stifel
12/16/20 Colliers
ElectraMeccanica initiated with a Buy at Colliers
11/23/20 Roth Capital
ElectraMeccanica price target raised to $12.25 from $7.50 at Roth Capital
10/29/20 Roth Capital
Roth reiterates Buy rating on ElectraMeccanica after first deliveries from China
OWL Blue Owl Capital
$13.63 /

+0.36 (+2.71%)

06/11/21 Goldman Sachs
Blue Owl Capital initiated with a Buy at Goldman Sachs
GT Goodyear Tire
$15.88 /

+0.23 (+1.47%)

05/04/21 Deutsche Bank
Goodyear Tire price target raised to $21 from $19 at Deutsche Bank
04/16/21
Fly Intel: Top five analyst downgrades
04/16/21 Morgan Stanley
Morgan Stanley downgrades Goodyear Tire to Equal Weight after 'strong run'
04/16/21 Morgan Stanley
Goodyear Tire downgraded to Equal Weight from Overweight at Morgan Stanley
XELA Exela Technologies
$2.92 /

+0.17 (+6.18%)

06/02/21 Cantor Fitzgerald
Exela Technologies initiated with an Overweight at Cantor Fitzgerald
CL Colgate-Palmolive
$82.19 /

-0.49 (-0.59%)

06/23/21 UBS
Colgate-Palmolive initiated with a Buy at UBS
06/09/21
Fly Intel: Top five analyst upgrades
06/09/21 Credit Suisse
Colgate-Palmolive upgraded to Outperform from Neutral at Credit Suisse
05/03/21 Deutsche Bank
Colgate-Palmolive price target raised to $85 from $84 at Deutsche Bank
VLDR Velodyne Lidar
$8.55 /

+0.12 (+1.42%)

07/20/21 Baird
Baird downgrades Velodyne Lidar on 'further uncertainty' after CEO exit
07/20/21 Baird
Velodyne Lidar downgraded to Neutral from Outperform at Baird
05/11/21 Needham
Velodyne Lidar price target lowered to $15 from $20 at Needham
04/20/21 BofA
Velodyne Lidar initiated with an Underperform at BofA
FTCV FinTech Acquisition Corp. V
$10.66 /

+0.15 (+1.43%)

XELA Exela Technologies
$2.92 /

+0.17 (+6.18%)

VLDR Velodyne Lidar
$8.55 /

+0.12 (+1.42%)

SOLO ElectraMeccanica
$3.73 /

+0.09 (+2.47%)

GT Goodyear Tire
$15.88 /

+0.23 (+1.47%)

GOEV Canoo
$8.76 /

+0.21 (+2.46%)

CL Colgate-Palmolive
$82.19 /

-0.49 (-0.59%)

VLDR Velodyne Lidar
$8.55 /

+0.12 (+1.42%)

OWL Blue Owl Capital
$13.63 /

+0.36 (+2.71%)

GT Goodyear Tire
$15.88 /

+0.23 (+1.47%)

GOEV Canoo
$8.76 /

+0.21 (+2.46%)

FTCV FinTech Acquisition Corp. V
$10.66 /

+0.15 (+1.43%)

CL Colgate-Palmolive
$82.19 /

-0.49 (-0.59%)

XELA Exela Technologies
$2.92 /

+0.17 (+6.18%)

VLDR Velodyne Lidar
$8.55 /

+0.12 (+1.42%)

OWL Blue Owl Capital
$13.63 /

+0.36 (+2.71%)

GT Goodyear Tire
$15.88 /

+0.23 (+1.47%)

GOEV Canoo
$8.76 /

+0.21 (+2.46%)

FTCV FinTech Acquisition Corp. V
$10.66 /

+0.15 (+1.43%)

CL Colgate-Palmolive
$82.19 /

-0.49 (-0.59%)

XELA Exela Technologies
$2.92 /

+0.17 (+6.18%)

VLDR Velodyne Lidar
$8.55 /

+0.12 (+1.42%)

SOLO ElectraMeccanica
$3.73 /

+0.09 (+2.47%)

OWL Blue Owl Capital
$13.63 /

+0.36 (+2.71%)

LIT Litton Ind
$81.61 /

+3.6 (+4.61%)

LABD Daily S&P Biotech Bear 3x Shares
$21.23 /

-0.71 (-3.24%)

GT Goodyear Tire
$15.88 /

+0.23 (+1.47%)

GOEV Canoo
$8.76 /

+0.21 (+2.46%)

FTCV FinTech Acquisition Corp. V
$10.66 /

+0.15 (+1.43%)

Hot Stocks
Tortoise Acquisition Corp. II partners with StreetLight for EV charging solution » 08:40
07/22/21
07/22
08:40
07/22/21
08:40
SNPR

Tortoise Acquisition Corp. II

$9.91 /

-0.045 (-0.45%)

Tortoise Acquisition…

Tortoise Acquisition Corp. II's combination agreement partner Volta Industries, a provider of commerce-centric electric vehicle - EV - charging networks, announced a strategic partnership with StreetLight Data, a provider of big data analytics for mobility, to use their combined analytics for the intelligent deployment of EV infrastructure. The partnership is intended to spur public sector agencies, utilities, transportation planners and engineering firms, among others, to accelerate EV adoption through Volta's PredictEV SaaS solution and StreetLight's mobility data. Volta Charging and Tortoise Acquisition Corp. II entered into a business combination agreement in February subject to customary closing conditions, under which the combined entity will be named Volta and remain on the NYSE under the new ticker symbol "VLTA". PredictEV is a machine-learning tool that helps utilities, municipalities and companies predict electric vehicle adoption and demand for EV charging. Through this partnership, Volta Charging will provide its PredictEV tool to StreetLight customers. StreetLight will also provide Volta Charging with opportunities to expand its market footprint across the U.S. through increased collaboration with transportation planners, engineering firms and public agencies focused on transportation electrification.

ShowHide Related Items >><<
SNPR Tortoise Acquisition Corp. II
$9.91 /

-0.045 (-0.45%)

SNPR Tortoise Acquisition Corp. II
$9.91 /

-0.045 (-0.45%)

SNPR Tortoise Acquisition Corp. II
$9.91 /

-0.045 (-0.45%)

SNPR Tortoise Acquisition Corp. II
$9.91 /

-0.045 (-0.45%)

Hot Stocks
Catalyst Biosciences announce first patient screened for CFI deficiency in study » 08:21
07/22/21
07/22
08:21
07/22/21
08:21
CBIO

Catalyst Biosciences

$4.60 /

+0.06 (+1.32%)

Catalyst Biosciences…

Catalyst Biosciences announced the screening of the first patient in its CFI-deficiency study in the CB 4332 program, its wholly-owned, first-in-class, enhanced Complement Factor I, intended for prophylactic subcutaneous administration in individuals with CFI deficiency. "The findings from the CFI deficiency screening and natural history of disease studies will be instrumental in identifying patients for the Phase 1/2 trial of CB 4332, planned for mid-year 2022," said Nassim Usman, Ph.D., president and chief executive officer of Catalyst. "Following the disease manifestations and biomarkers of this complement disorder will be important in unlocking the full therapeutic potential of CB 4332." The ConFIrm screening study will measure CFI levels and activity in patients who have diseases related to a CFI deficiency and who may potentially benefit from CB 4332 treatment. The ConFIdence natural history of disease study will follow these CFI-deficient subjects, who often present with repetitive bacterial infections, immune-related diseases, and/or glomerulopathies, for clinical biomarkers and safety of current treatments. The findings from these studies will identify opportunities to potentially develop CB 4332 for treatment in multiple indications.

ShowHide Related Items >><<
CBIO Catalyst Biosciences
$4.60 /

+0.06 (+1.32%)

CBIO Catalyst Biosciences
$4.60 /

+0.06 (+1.32%)

07/19/21 Piper Sandler
Piper remains Overweight on Catalyst Biosciences following R&D day
07/09/21 Chardan
Catalyst Biosciences coverage transferred at Chardan
04/29/21 Raymond James
Catalyst Biosciences assumed with an Outperform at Raymond James
04/28/21 Piper Sandler
Catalyst Biosciences should be bought 'right here,' says Piper Sandler
CBIO Catalyst Biosciences
$4.60 /

+0.06 (+1.32%)

  • 27
    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.